These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2974746)

  • 21. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
    Girault JA; Spampinato U; Glowinski J; Besson MJ
    Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.
    Li R; Chuang DM; Wyatt RJ; Kirch DG
    Neurochem Res; 1994 Jun; 19(6):673-8. PubMed ID: 8065524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
    Altar CA; Boyar WC; Kim HS
    Eur J Pharmacol; 1990 May; 181(1-2):17-21. PubMed ID: 1974856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?
    Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC
    Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential actions of dopamine receptor subtypes on gonadotropin and growth hormone release in vitro in goldfish.
    Chang JP; Yu KL; Wong AO; Peter RE
    Neuroendocrinology; 1990 Jun; 51(6):664-74. PubMed ID: 2141920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release.
    Gorell JM; Czarnecki B; Hubbell S
    Life Sci; 1986 Jun; 38(24):2247-54. PubMed ID: 2940433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors labelled by [3H]quinpirole.
    Seeman P; Schaus JM
    Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
    Evans AM; Green KL
    Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bidirectional regulation of cAMP generating system by dopamine-D1 and D2-receptors in the rat retina.
    Nowak JZ; Sek B; Schorderet M
    J Neural Transm Gen Sect; 1990; 81(3):235-40. PubMed ID: 1697754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum.
    Conzelmann U; Holland A; Meyer DK
    Eur J Pharmacol; 1984 May; 101(1-2):119-25. PubMed ID: 6235119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium.
    Rump LC; Riera-Knorrenschild G; Schwertfeger E; Bohmann C; Spillner G; Schollmeyer P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):462-70. PubMed ID: 8583789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.
    Drukarch B; Schepens E; Stoof JC
    Eur J Pharmacol; 1991 Apr; 196(2):209-12. PubMed ID: 1678719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of dopamine receptors associated with steroid secretion in frog adrenocortical cells.
    Morra M; Leboulenger F; Vaudry H
    J Mol Endocrinol; 1992 Feb; 8(1):43-52. PubMed ID: 1543533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.